The ineffective management of supply chains by manufacturers and distributors has allowed counterfeiters and smugglers to evolve rapidly and become very creative and excel in producing counterfeit medicines and inserting them into the legitimate supply chains, meaning that many fake medicines go undetected. To counter this issue, global organizations, such as the World Health Organization (WHO), the European Union (EU), and the US Food and Drug Administration (FDA), work together to protect the safety and security of patients through pharma supply chain security.
Evolution in Supply Chain Management
DSCSA (Drug Supply Chain Security Act) established a 10-year roadmap with enforcement and adaptations in 2015 and 2018 related to Product Tracing, Product identifiers, Authorized Trading Partners, and Verification. The last section of the law, is Electronic Drug Distribution Security (EDDS). Among other things, EDDS directs all trading partners to have in place a secure, electronic, and interoperable system for the exchange of transaction documentation [transaction information (TI) and transaction statements (TS)] to enable the tracing of prescription medications.
Features:
Graphs, charts, tables and visualizations complement the analysis
Forecasts, projections of future market activity are derived using standard modeling and statistical techniques.
What You Will Learn:
Provides detailed analysis DSCSA strategies, and workflow component factors.
Assesses key stakeholders, market dynamics and market demographics.
Analyzes therapeutic demand drivers and evaluates readiness in key supply chain segments.
Provides market data and forecasts.
Profiles market sector participants, their market activities, business strategies, and corporate alliances and affiliations
Assesses the importance of alliances and partnerships on DSCSA implementation.
Evaluates the impact of supply chain security economic, technology, and regulatory factors.
Table of Contents
Executive Summary
Pharma Supply Chain Security
Executive Summary
Drug Safety vs Drug Security
A Paradigm Shift in Healthcare Integrity
DSCSA Objectives
DSCSA Implementation
Overview of Product Tracing
Track and Tracing
Threats to Drug Security
Counterfeiting
Packaging for Drug Security
Track and Trace
Tamper Evident Packaging
Enabling Drug Security Technologies
Serialization
Bluetooth
Wireless Options for Drug Security
Near Field Communication
RFID
Wireless Architectures
Digital Healthcare and Cybersecurity
Medical Applications for NFC
UDI
Hospital Inventory Tracking Solutions
In-patient Management
Threats to Drug Security
Physical Security
Blockchain
Counterfeiting
Optical variable devices
Watermark
Security threats
Security foils
Optically Variable Inks/Color shifting Inks
Intaglio printing
Laser marking
Magnetic strip
Micro/nano printing
Hidden imagery
Polarization imagery
Security inks
Nanoparticles
Packaging for Drug Security
Drug Distribution Security
Track and Trace
Unit Dose Packaging
Holograms
Optically Variable Ink
Color Shifting Inks
Enabling Drug Security Technologies
Interoperability
Serialization
Regulations
The Drug Supply Chain Security Act (DSCSA)
DSCSA Requirements for Pharmacies and Retail Entities
United States Legislative Programs
Automation of Reports and Consolidated Orders System (ARCOS)